{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-019351","form_type":"8-K","ticker":"SQFT","cik":"0001080657","company_name":"Presidio Property Trust, Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.201824+00:00","generated_at":"2026-06-01T22:33:25.003212+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Presidio Property Trust Q1 net loss widens to $5.8M; common dividend suspended","bullets":["Net loss attributable to common stockholders: $5.8M ($0.47/sh) vs $1.5M ($0.13/sh) in Q1 2023.","Total revenues increased to $4.8M from $4.1M; model home sales rose to 27 homes with $2.0M gain.","Non-cash impairment of $0.1M on four model homes; fair value loss on Conduit Pharmaceuticals securities of $3.9M.","FFO worsened to ($971,367) from ($228,914); Core FFO negative ($429,445) vs positive $31,932 year ago.","Series A common dividend declared $0.00 in Q1 2024 vs $0.022 in Q1 2023; Series D preferred steady at $0.58593."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-019351","json":"https://secwatch.observer/filing/0001493152-24-019351.json","markdown":"https://secwatch.observer/filing/0001493152-24-019351.md","text":"https://secwatch.observer/filing/0001493152-24-019351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1080657/000149315224019351/0001493152-24-019351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1080657/000149315224019351/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:33:25.003212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32e857c199c10bbec9b4cf51268e501bd0cbd5f1","claim":"Presidio Property Trust, Inc. reported three months ended March 31, 2024 results: revenue $4.8 million, net income approximately $5.8 million, EPS ($0.47) per basic and diluted share.","evidence_excerpt":"for the three months ended March 31, 2023. The change in net income attributable to the Company’s common stockholders was a result of: ● Total revenues were approximately $4.8 million for the three months ended March 31, 2024, compared to approximately $4.1 million for the same period in 2023. As of March 31, 2024, we had approximately $135.3 million in net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1080657/000149315224019351/0001493152-24-019351-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$4.8 million"},{"label":"Net income","value":"approximately $5.8 million"},{"label":"EPS","value":"($0.47) per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}